Literature DB >> 26790475

Cardiac adipose tissue and atrial fibrillation: the perils of adiposity.

Stéphane N Hatem1, Alban Redheuil2, Estelle Gandjbakhch3.   

Abstract

The amount of adipose tissue that accumulates around the atria is associated with the risk, persistence, and severity of atrial fibrillation (AF). A strong body of clinical and experimental evidence indicates that this relationship is not an epiphenomenon but is the result of complex crosstalk between the adipose tissue and the neighbouring atrial myocardium. For instance, epicardial adipose tissue is a major source of adipokines, inflammatory cytokines, or reactive oxidative species, which can contribute to the fibrotic remodelling of the atrial myocardium. Fibro-fatty infiltrations of the subepicardium could also contribute to the functional disorganization of the atrial myocardium. The observation that obesity is associated with distinct structural and functional remodelling of the atria has opened new perspectives of treating AF substrate with aggressive risk factor management. Advances in cardiac imaging should lead to an improved ability to visualize myocardial fat depositions and to localize AF substrates. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Adipokines; Adipose tissue; Atrial fibrillation; Atrial fibrosis

Mesh:

Year:  2016        PMID: 26790475     DOI: 10.1093/cvr/cvw001

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  38 in total

1.  Deciphering the fundamental mechanisms of atrial fibrillation: a quest for over a century.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Cardiovasc Res       Date:  2016-02-07       Impact factor: 10.787

2.  Increased Epicardial Fat Volume Is Independently Associated with the Presence and Severity of Systemic Sclerosis.

Authors:  Benjamin D Long; Jadranka Stojanovska; Richard K J Brown; Anil K Attili; Eizabeth A Jackson; Vladimir Ognenovski
Journal:  Acad Radiol       Date:  2017-08-26       Impact factor: 3.173

Review 3.  Interplay between cardiac transcription factors and non-coding RNAs in predisposing to atrial fibrillation.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  J Mol Med (Berl)       Date:  2018-05-12       Impact factor: 4.599

4.  Obesity-associated alterations in cardiac connexin-43 and PKC signaling are attenuated by melatonin and omega-3 fatty acids in female rats.

Authors:  Tamara Egan Benova; Csilla Viczenczova; Barbara Szeiffova Bacova; Vladimir Knezl; Victor Dosenko; Hana Rauchova; Michal Zeman; Russel J Reiter; Narcis Tribulova
Journal:  Mol Cell Biochem       Date:  2018-11-16       Impact factor: 3.396

5.  Laser catheter ablation of long- lasting persistent atrial fibrillation: Longterm results.

Authors:  Helmut Weber; Michaela Sagerer-Gerhardt; Armin Heinze
Journal:  J Atr Fibrillation       Date:  2017-08-31

Review 6.  Towards a Mechanistic Understanding and Treatment of a Progressive Disease: Atrial Fibrillation.

Authors:  Felix Yang; Joseph Tiano; Suneet Mittal; Mintu Turakhia; Israel Jacobowitz; Yisachar Greenberg
Journal:  J Atr Fibrillation       Date:  2017-10-31

Review 7.  Atrial Fibrillation Susceptibility in Obesity: An Excess Adiposity and Fibrosis Complicity?

Authors:  Sandeep V Pandit; Justus Anumonwo; José Jalife
Journal:  Circ Res       Date:  2016-05-13       Impact factor: 17.367

Review 8.  Epicardial Adipose Tissue and Cardiovascular Disease.

Authors:  Thierry H Le Jemtel; Rohan Samson; Karnika Ayinapudi; Twinkle Singh; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2019-04-05       Impact factor: 5.369

9.  Pitx2 maintains mitochondrial function during regeneration to prevent myocardial fat deposition.

Authors:  Lele Li; Ge Tao; Matthew C Hill; Min Zhang; Yuka Morikawa; James F Martin
Journal:  Development       Date:  2018-09-26       Impact factor: 6.868

10.  Body Composition in Patients with Atrial Fibrillation.

Authors:  Marzena Anaszewicz; Wioletta Banaś; Anna Wawrzeńczyk; Jacek Budzyński
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.